1/16
12:56 pm
ocgn
Ocugen: Why I Don't Read Too Much Into The Selloff On Phase 2 GA Data [Seeking Alpha]
Low
Report
Ocugen: Why I Don't Read Too Much Into The Selloff On Phase 2 GA Data [Seeking Alpha]
1/15
07:02 pm
ocgn
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration [Yahoo! Finance]
Medium
Report
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration [Yahoo! Finance]
1/15
08:15 am
ocgn
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
High
Report
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
1/13
12:41 pm
ocgn
Why The Narrative Around Ocugen (OCGN) Is Shifting After New Fair Value Updates [Yahoo! Finance]
Medium
Report
Why The Narrative Around Ocugen (OCGN) Is Shifting After New Fair Value Updates [Yahoo! Finance]
1/13
07:00 am
ocgn
Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data
Medium
Report
Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data
1/12
06:46 am
ocgn
Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy [Yahoo! Finance]
High
Report
Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy [Yahoo! Finance]
1/12
06:30 am
ocgn
Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy
High
Report
Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy
1/10
05:37 pm
ocgn
Ocugen (OCGN) Valuation Check As Social Media Speculation Lifts Interest In Gene Therapy Prospects [Yahoo! Finance]
High
Report
Ocugen (OCGN) Valuation Check As Social Media Speculation Lifts Interest In Gene Therapy Prospects [Yahoo! Finance]
1/9
07:16 am
ocgn
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference [Yahoo! Finance]
Neutral
Report
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference [Yahoo! Finance]
1/9
07:02 am
ocgn
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference
Neutral
Report
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference
1/9
02:37 am
ocgn
Is Social Media Now Defining Ocugen's (OCGN) Gene Therapy Investment Story More Than Its Science? [Yahoo! Finance]
Low
Report
Is Social Media Now Defining Ocugen's (OCGN) Gene Therapy Investment Story More Than Its Science? [Yahoo! Finance]
1/6
12:49 am
ocgn
Ocugen: Maintaining 'Buy' Rating On Positive OCU410ST Regulatory Developments [Seeking Alpha]
Medium
Report
Ocugen: Maintaining 'Buy' Rating On Positive OCU410ST Regulatory Developments [Seeking Alpha]
12/10
10:34 am
ocgn
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit [Yahoo! Finance]
Low
Report
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit [Yahoo! Finance]
12/10
09:20 am
ocgn
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
Low
Report
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
11/29
09:23 pm
ocgn
How the Narrative Surrounding Ocugen Is Shifting After New Licensing and Analyst Developments [Yahoo! Finance]
Medium
Report
How the Narrative Surrounding Ocugen Is Shifting After New Licensing and Analyst Developments [Yahoo! Finance]
11/20
07:50 am
ocgn
Ocugen CEO to Present at NobleCon21—Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference [Yahoo! Finance]
Low
Report
Ocugen CEO to Present at NobleCon21—Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference [Yahoo! Finance]
11/20
07:02 am
ocgn
Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference
Medium
Report
Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference
11/15
08:21 pm
ocgn
How Recent Developments Are Rewriting the Story for Ocugen [Yahoo! Finance]
Medium
Report
How Recent Developments Are Rewriting the Story for Ocugen [Yahoo! Finance]
11/9
08:23 pm
ocgn
Ocugen Inc (OCGN) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]
Neutral
Report
Ocugen Inc (OCGN) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]
11/5
04:27 pm
ocgn
Ocugen outlines plans for three BLA filings in next three years amid global gene therapy expansion [Seeking Alpha]
Medium
Report
Ocugen outlines plans for three BLA filings in next three years amid global gene therapy expansion [Seeking Alpha]
11/5
06:30 am
ocgn
Ocugen Provides Business Update with Third Quarter 2025 Financial Results
Low
Report
Ocugen Provides Business Update with Third Quarter 2025 Financial Results
10/23
07:30 am
ocgn
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
Low
Report
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
10/18
04:14 am
ocgn
What Catalysts Could Shift the Ocugen Story After Recent Analyst Reactions and News? [Yahoo! Finance]
Neutral
Report
What Catalysts Could Shift the Ocugen Story After Recent Analyst Reactions and News? [Yahoo! Finance]